Foghorn Therapeutics (FHTX)

Foghorn Therapeutics (FHTX) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• FHTX last traded at $2.08, -0.48% on the day.
• Foghorn Therapeutics: P/E -2.1, revenue $36.74M over the last four quarters.
• Over the past year FHTX returned -51.74%; year to date -61.48%.

Updated 2026-11-02 17:57 UTC